Clinical trial
A Single-Arm, Exploratory Clinical Study of Adebrelimab Combined With S-1 in Patients With Resected Cholangiocarcinoma
NCT07561775 is registered in ClinicalTrials.gov with Xingjun Guo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Arm, Exploratory Clinical Study of Adebrelimab Combined With S-1 in Patients With Resected Cholangiocarcinoma
- Lead sponsor
- Xingjun Guo
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- April 21, 2026
- Completion date
- January 1, 2032
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
biliary tract cancer, cholangiocarcinoma